Hh Signaling Antagonist VII, JK184
CAS: 315703-52-7
Rif. 3D-QMA70352
| 50mg | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta |
Informazioni sul prodotto
- Jk184
Hh Signaling Antagonist VII, JK184 is a polymerase chain reaction (PCR) primer that was designed to detect the Hh signaling pathway in muscle cells. It has been shown to be effective in treating muscle diseases such as muscular dystrophy and Duchenne muscular dystrophy. The Hh signaling antagonist has also been shown to promote the differentiation of pluripotent stem cells into muscle cells and reduce the size of metastatic pancreatic cancer tumors by inhibiting tumor growth. This drug also has an effect on glucose regulation and diabetic neuropathy, including transcriptional regulation, cell growth, and biological function.
Proprietà chimiche
Richiesta tecnica su: 3D-QMA70352 Hh Signaling Antagonist VII, JK184
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
